Search by Drug Name or NDC

    NDC 69097-0261-05 SOLIFENACINE SUCCINATE 10 mg/1 Details

    SOLIFENACINE SUCCINATE 10 mg/1

    SOLIFENACINE SUCCINATE is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Cipla USA Inc.. The primary component is SOLIFENACIN SUCCINATE.

    Product Information

    NDC 69097-0261
    Product ID 69097-261_13de71d6-5be1-49ee-b2cf-e3d7c8fd7b45
    Associated GPIs 54100055200330
    GCN Sequence Number 057983
    GCN Sequence Number Description solifenacin succinate TABLET 10 MG ORAL
    HIC3 R1I
    HIC3 Description URINARY TRACT ANTISPASMODIC, M(3) SELECTIVE ANTAG.
    GCN 23277
    HICL Sequence Number 026595
    HICL Sequence Number Description SOLIFENACIN SUCCINATE
    Brand/Generic Generic
    Proprietary Name SOLIFENACINE SUCCINATE
    Proprietary Name Suffix n/a
    Non-Proprietary Name solifenacine succinate
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 10
    Active Ingredient Units mg/1
    Substance Name SOLIFENACIN SUCCINATE
    Labeler Name Cipla USA Inc.
    Pharmaceutical Class Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA209839
    Listing Certified Through 2024-12-31

    Package

    NDC 69097-0261-05 (69097026105)

    NDC Package Code 69097-261-05
    Billing NDC 69097026105
    Package 90 TABLET in 1 BOTTLE (69097-261-05)
    Marketing Start Date 2019-05-20
    NDC Exclude Flag N
    Pricing Information N/A